A learning curve in medication adherence

Chris Evans, reveals how West recently announced a collaboration with Noble to develop validated training solutions for self-injection systems

Several biologics coming onto the market offer the potential to make a difference in the lives of patients with incurable-but-controllable conditions such as diabetes and Crohn’s disease. These innovative therapeutics aim to improve patients’ quality of life by not only reducing symptoms, but also offering new independence enabled by at-home treatment.

View full story >

Posted by